申请人:Adir et Compagnie
公开号:US05079245A1
公开(公告)日:1992-01-07
The compounds 2-trifluoromethyl-7-substituted-6,7,8,9-tetrahydro-[5H]-benzocycloheptenes are disclosed and disclosed to be useful in the treatment of metabolic illnesses such as diabetes, obesity, and their complications. A perferred compound is 2-trifluoromethyl-7-amino-6,7,8,9-tetrahydro-[5H-benzocycloheptane.
化合物2-三氟甲基-7-取代-6,7,8,9-四氢-[5H]-苯并环庚烯已被披露,并被披露为在治疗代谢性疾病如糖尿病、肥胖及其并发症方面有用。首选化合物是2-三氟甲基-7-氨基-6,7,8,9-四氢-[5H]-苯并环庚烷。